Evolent Health, Inc. (EVH)
AI stock analysis · Health Information Services · Last analyzed Aug 18, 2026
Evolent Health is executing a high-growth specialty care management strategy, delivering 46.9% YoY revenue growth driven by expanding oncology and complex condition management contracts with health plans. The forward P/E of 11.4x is compelling if management converts top-line momentum into sustained profitability, and the broad analyst Buy consensus reflects confidence in that trajectory. The key risk is that the company remains loss-making, and any deterioration in managed care utilization trends or contract losses could pressure both revenue and the path to profitability.
- Continued signing of new health plan partnerships or contract expansions in oncology care management, which could drive further 40%+ revenue growth into the next fiscal year.
- A credible inflection toward GAAP profitability or raised forward earnings guidance in the upcoming quarterly report, validating the 11.4x forward P/E thesis.
- Broader managed care sector tailwinds from health plans accelerating outsourcing of specialty cost management, expanding Evolent's total addressable market.
- Sustained losses with no clear GAAP profitability timeline — if margin improvement stalls, the current valuation loses its anchor and the stock could de-rate sharply.
- Customer concentration risk: loss or non-renewal of a major health plan contract could cause a disproportionate revenue hit given the early-stage client base.
- Macroeconomic and regulatory pressure on managed care organizations (MCOs) could reduce their appetite for outsourced specialty programs, directly slowing Evolent's growth engine.
Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.
Start free for 3 days →Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →